請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/59807
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 沈麗娟 | |
dc.contributor.author | Pei-Yu Hsieh | en |
dc.contributor.author | 謝佩妤 | zh_TW |
dc.date.accessioned | 2021-06-16T09:38:59Z | - |
dc.date.available | 2022-02-24 | |
dc.date.copyright | 2017-02-24 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2017-02-09 | |
dc.identifier.citation | 1. U.S. Food and Drug Administration. CDER New Molecular Entity (NME) and Original Biologic Approvals. http://fda.gob/Drugs/developmentapprovalprocess (accessed Oct 25, 2016)
2. Banting, F.G., et al., Pancreatic Extracts in the Treatment of Diabetes Mellitus. Can Med Assoc J, 1922. 12(3): p. 141-6. 3. Souza, L.M., et al., Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science, 1986. 232(4746): p. 61-5. 4. Hudis, C.A., Trastuzumab--mechanism of action and use in clinical practice. N Engl J Med, 2007. 357(1): p. 39-51. 5. Scheinfeld, N., Adalimumab (HUMIRA): a review. J Drugs Dermatol, 2003. 2(4): p. 375-7. 6. Patel, L.N., J.L. Zaro, and W.C. Shen, Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res, 2007. 24(11): p. 1977-92. 7. Madani, F., et al., Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys, 2011. 2011: p. 414729. 8. Green, M. and P.M. Loewenstein, Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell, 1988. 55(6): p. 1179-88. 9. Derossi, D., et al., The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem, 1994. 269(14): p. 10444-50. 10. Zorko, M. and U. Langel, Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv Drug Deliv Rev, 2005. 57(4): p. 529-45. 11. Farkhani, S.M., et al., Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules. Peptides, 2014. 57: p. 78-94. 12. Rothbard, J.B., et al., Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med, 2000. 6(11): p. 1253-7. 13. Mo, R.H., J.L. Zaro, and W.C. Shen, Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy. Mol Pharm, 2012. 9(2): p. 299-309. 14. Sayers, E.J., et al., Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides. J Control Release, 2014. 195: p. 55-62. 15. Eiriksdottir, E., et al., Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates. Bioconjug Chem, 2010. 21(9): p. 1662-72. 16. Pethe, K., et al., The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature, 2001. 412(6843): p. 190-4. 17. Menozzi, F.D., et al., Mycobacterium tuberculosis heparin-binding haemagglutinin adhesin (HBHA) triggers receptor-mediated transcytosis without altering the integrity of tight junctions. Microbes Infect, 2006. 8(1): p. 1-9. 18. Menozzi, F.D., et al., Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med, 1996. 184(3): p. 993-1001. 19. Delogu, G. and M.J. Brennan, Functional domains present in the mycobacterial hemagglutinin, HBHA. J Bacteriol, 1999. 181(24): p. 7464-9. 20. Henriques, S.T. and M.A. Castanho, Consequences of nonlytic membrane perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic vesicles. Biochemistry, 2004. 43(30): p. 9716-24. 21. Ter-Avetisyan, G., et al., Cell entry of arginine-rich peptides is independent of endocytosis. J Biol Chem, 2009. 284(6): p. 3370-8. 22. Simeoni, F., et al., Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res, 2003. 31(11): p. 2717-24. 23. Swanson, J.A. and C. Watts, Macropinocytosis. Trends Cell Biol, 1995. 5(11): p. 424-8. 24. McMahon, H.T. and E. Boucrot, Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol, 2011. 12(8): p. 517-33. 25. Rothberg, K.G., et al., Caveolin, a protein component of caveolae membrane coats. Cell, 1992. 68(4): p. 673-82. 26. Lim, J.P. and P.A. Gleeson, Macropinocytosis: an endocytic pathway for internalising large gulps. Immunol Cell Biol, 2011. 89(8): p. 836-43. 27. Pelkmans, L., Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim Biophys Acta, 2005. 1746(3): p. 295-304. 28. Hinshaw, J.E., Dynamin and its role in membrane fission. Annu Rev Cell Dev Biol, 2000. 16: p. 483-519. 29. Tyagi, M., et al., Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem, 2001. 276(5): p. 3254-61. 30. Silhol, M., et al., Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem, 2002. 269(2): p. 494-501. 31. Desai, N., Challenges in development of nanoparticle-based therapeutics. AAPS J, 2012. 14(2): p. 282-95. 32. Park, I.K., et al., Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier. J Control Release, 2000. 69(1): p. 97-108. 33. Lee, E.S., et al., Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization. J Control Release, 2003. 90(3): p. 363-74. 34. Gatenby, R.A. and R.J. Gillies, Why do cancers have high aerobic glycolysis? Nat Rev Cancer, 2004. 4(11): p. 891-9. 35. Warburg, O., On the origin of cancer cells. Science, 1956. 123(3191): p. 309-14. 36. Stubbs, M., C.L. Bashford, and J.R. Griffiths, Understanding the tumor metabolic phenotype in the genomic era. Curr Mol Med, 2003. 3(1): p. 49-59. 37. Semenza, G.L., Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 2003. 3(10): p. 721-32. 38. Volk, T., et al., pH in human tumour xenografts: effect of intravenous administration of glucose. Br J Cancer, 1993. 68(3): p. 492-500. 39. Yeh, T.H., et al., Selective intracellular delivery of recombinant arginine deiminase (ADI) using pH-sensitive cell penetrating peptides to overcome ADI resistance in hypoxic breast cancer cells. Mol Pharm, 2015. 40. Shimomura, O., F.H. Johnson, and Y. Saiga, Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J Cell Comp Physiol, 1962. 59: p. 223-39. 41. Morise, H., et al., Intermolecular energy transfer in the bioluminescent system of Aequorea. Biochemistry, 1974. 13(12): p. 2656-62. 42. Prasher, D.C., et al., Primary structure of the Aequorea victoria green-fluorescent protein. Gene, 1992. 111(2): p. 229-33. 43. Chalfie, M., et al., Green fluorescent protein as a marker for gene expression. Science, 1994. 263(5148): p. 802-5. 44. Inouye, S. and F.I. Tsuji, Aequorea green fluorescent protein. Expression of the gene and fluorescence characteristics of the recombinant protein. FEBS Lett, 1994. 341(2-3): p. 277-80. 45. Heim, R., A.B. Cubitt, and R.Y. Tsien, Improved green fluorescence. Nature, 1995. 373(6516): p. 663-4. 46. Tsien, R.Y., The green fluorescent protein. Annu Rev Biochem, 1998. 67: p. 509-44. 47. Shaner, N.C., P.A. Steinbach, and R.Y. Tsien, A guide to choosing fluorescent proteins. Nat Methods, 2005. 2(12): p. 905-9. 48. Chudakov, D.M., et al., Fluorescent proteins and their applications in imaging living cells and tissues. Physiol Rev, 2010. 90(3): p. 1103-63. 49. Yang, F., L.G. Moss, and G.N. Phillips, Jr., The molecular structure of green fluorescent protein. Nat Biotechnol, 1996. 14(10): p. 1246-51. 50. Ormo, M., et al., Crystal structure of the Aequorea victoria green fluorescent protein. Science, 1996. 273(5280): p. 1392-5. 51. Fittipaldi, A., et al., Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem, 2003. 278(36): p. 34141-9. 52. Ferrari, A., et al., Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol Ther, 2003. 8(2): p. 284-94. 53. Nishi, K. and K. Saigo, Cellular internalization of green fluorescent protein fused with herpes simplex virus protein VP22 via a lipid raft-mediated endocytic pathway independent of caveolae and Rho family GTPases but dependent on dynamin and Arf6. J Biol Chem, 2007. 282(37): p. 27503-17. 54. Kwon, S.J., et al., Transduction of the MPG-tagged fusion protein into mammalian cells and oocytes depends on amiloride-sensitive endocytic pathway. BMC Biotechnol, 2009. 9: p. 73. 55. Rothe, R., et al., Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator. J Biol Chem, 2010. 285(26): p. 20224-33. 56. Terpe, K., Overview of tag protein fusions: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol, 2003. 60(5): p. 523-33. 57. Bulow, L., Preparation of artificial bifunctional enzymes by gene fusion. Biochem Soc Symp, 1990. 57: p. 123-33. 58. Bird, R.E., et al., Single-chain antigen-binding proteins. Science, 1988. 242(4877): p. 423-6. 59. Zhao, H.L., et al., Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha2b fusion protein by linker engineering. Protein Expr Purif, 2008. 61(1): p. 73-7. 60. Amet, N., H.F. Lee, and W.C. Shen, Insertion of the designed helical linker led to increased expression of tf-based fusion proteins. Pharm Res, 2009. 26(3): p. 523-8. 61. Bai, Y., D.K. Ann, and W.C. Shen, Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci U S A, 2005. 102(20): p. 7292-6. 62. Bai, Y. and W.C. Shen, Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization. Pharmaceutical Research, 2006. 23(9): p. 2116-2121. 63. George, R.A. and J. Heringa, An analysis of protein domain linkers: their classification and role in protein folding. Protein Engineering, 2002. 15(11): p. 871-879. 64. Argos, P., An Investigation of Oligopeptides Linking Domains in Protein Tertiary Structures and Possible Candidates for General Gene Fusion. Journal of Molecular Biology, 1990. 211(4): p. 943-958. 65. Huston, J.S., et al., Protein Engineering of Antibody-Binding Sites - Recovery of Specific Activity in an Anti-Digoxin Single-Chain Fv Analog Produced in Escherichia-Coli. Proceedings of the National Academy of Sciences of the United States of America, 1988. 85(16): p. 5879-5883. 66. Sabourin, M., et al., A flexible protein linker improves the function of epitope-tagged proteins in Saccharomyces cerevisiae. Yeast, 2007. 24(1): p. 39-45. 67. Aurora, R., et al., Local interactions in protein folding: Lessons from the alpha-helix. Journal of Biological Chemistry, 1997. 272(3): p. 1413-1416. 68. Chen, X., et al., Design of an in vivo cleavable disulfide linker in recombinant fusion proteins. Biotechniques, 2010. 49(1): p. 513-8. 69. Thorpe, P.E., et al., New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Cancer Res, 1987. 47(22): p. 5924-31. 70. Singh, V. and R. Curtiss, 3rd, Effect of amino group modification of ovine luteinizing hormone (oLH) by N-succinimidyl 6-[3-(2-pyridyldithio)propionate]hexanoate, a long chain N-succinimidyl-3-(2-pyridyldithio) propionate (SPDP) on immunological and biological properties: a comparative study with SPDP modified oLH. Mol Cell Biochem, 1994. 130(1): p. 83-90. 71. Zhao, H.L., et al., Balancing the pharmacokinetics and pharmacodynamics of interferon-alpha2b and human serum albumin fusion protein by proteolytic or reductive cleavage increases its in vivo therapeutic efficacy. Mol Pharm, 2012. 9(3): p. 664-70. 72. Koivusalo, M., et al., Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. Journal of Cell Biology, 2010. 188(4): p. 547-563. 73. Yao, D.Y., et al., Transforming growth factor-beta receptors interact with AP2 by direct binding to beta 2 subunit. Molecular Biology of the Cell, 2002. 13(11): p. 4001-4012. 74. Wang, L.H., K.G. Rothberg, and R.G. Anderson, Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol, 1993. 123(5): p. 1107-17. 75. Smart, E.J. and R.G.W. Anderson, Alterations in membrane cholesterol that affect structure and function of caveolae. Redox Cell Biology and Genetics, Pt B, 2002. 353: p. 131-139. 76. Ros-Baro, A., et al., Lipid rafts are required for GLUT4 internalization in adipose cells. Proceedings of the National Academy of Sciences of the United States of America, 2001. 98(21): p. 12050-12055. 77. Macia, E., et al., Dynasore, a cell-permeable inhibitor of dynamin. Developmental Cell, 2006. 10(6): p. 839-850. 78. Vander Heiden, M.G., L.C. Cantley, and C.B. Thompson, Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 2009. 324(5930): p. 1029-33. 79. Betty Revon Liu, M.-H.C., Hwei-Hsien Chen, Shih-Yen Lo, and Y.-W.H.a.H.-J. Lee, Effects of Surface Charge and Particle Size of Cell-Penetrating Peptide/Nanoparticle Complexes on Cellular Internalization. Cell Membrane. 2013, Hauppauge, New York,: Nova Science Publishers Inc. 80. Holt, G.D., M.K. Pangburn, and V. Ginsburg, Properdin Binds to Sulfatide [Gal(3-So4)Beta-1-1cer] and Has a Sequence Homology with Other Proteins That Bind Sulfated Glycoconjugates. Journal of Biological Chemistry, 1990. 265(5): p. 2852-2855. 81. Holt, G.D., et al., Antistasin, an inhibitor of coagulation and metastasis, binds to sulfatide (Gal(3-SO4) beta 1-1Cer) and has a sequence homology with other proteins that bind sulfated glycoconjugates. J Biol Chem, 1989. 264(21): p. 12138-40. 82. Steinman, R.M. and Z.A. Cohn, Interaction of Soluble Horseradish-Peroxidase with Mouse Peritoneal Macrophages in-Vitro. Journal of Cell Biology, 1972. 55(1): p. 186-&. 83. Steinman, R.M., J.M. Silver, and Z.A. Cohn, Pinocytosis in Fibroblasts - Quantitative Studies Invitro. Journal of Cell Biology, 1974. 63(3): p. 949-969. 84. Koivusalo, M., et al., Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling (vol 188, pg 547, 2010). Journal of Cell Biology, 2010. 189(2). 85. Zhang, S.L., H.J. Gao, and G. Bao, Physical Principles of Nanoparticle Cellular Endocytosis. Acs Nano, 2015. 9(9): p. 8655-8671. 86. Chakraborty, A. and N.R. Jana, Clathrin to Lipid Raft-Endocytosis via Controlled Surface Chemistry and Efficient Perinuclear Targeting of Nanoparticle. Journal of Physical Chemistry Letters, 2015. 6(18): p. 3688-3697. 87. Vercauteren, D., et al., The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls. Molecular Therapy, 2010. 18(3): p. 561-569. 88. Maruoka, N., et al., Effects of chlorpromazine on plasma membrane permeability and fluidity in the rat brain: A dynamic positron autoradiography and fluorescence polarization study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2007. 31(1): p. 178-186. 89. Ogiso, T., M. Iwaki, and K. Mori, Fluidity of Human-Erythrocyte Membrane and Effect of Chlorpromazine on Fluidity and Phase-Separation of Membrane. Biochimica Et Biophysica Acta, 1981. 649(2): p. 325-335. 90. Yde, C.W., et al., The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells. Anti-Cancer Drugs, 2009. 20(8): p. 723-735. 91. Walenga, R.W., E.E. Opas, and M.B. Feinstein, Differential effects of calmodulin antagonists on phospholipases A2 and C in thrombin-stimulated platelets. J Biol Chem, 1981. 256(23): p. 12523-8. 92. Amyere, M., et al., Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C. Mol Biol Cell, 2000. 11(10): p. 3453-67. 93. Veithen, A., et al., v-Src induces constitutive macropinocytosis in rat fibroblasts. J Cell Sci, 1996. 109 ( Pt 8): p. 2005-12. 94. Shigematsu, S., et al., The adipocyte plasma membrane caveolin functional/structural organization is necessary for the efficient endocytosis of GLUT4. J Biol Chem, 2003. 278(12): p. 10683-90. 95. Meier, O., et al., Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol, 2002. 158(6): p. 1119-31. 96. Dutta, D. and J.G. Donaldson, Search for inhibitors of endocytosis: Intended specificity and unintended consequences. Cell Logist, 2012. 2(4): p. 203-208. 97. Hakoyama, H., et al., Difference in parasite load and nonspecific immune reaction between sexual and gynogenetic forms of Carassius auratus. Biological Journal of the Linnean Society, 2001. 72(3): p. 401-407. 98. Weng, T.T., N.L. Jin, and L. Liu, Differentiation between amplicon polymerization and nonspecific products in SYBR green I real-time polymerase chain reaction. Analytical Biochemistry, 2005. 342(1): p. 167-169. 99. Baranovsky, V., et al., Nonspecific Interactions in Polymer Polymer Reactions .4. Complex-Formation between Polyacrylic-Acid and Monosubstituted Poly(Ethylene Glycol)S. European Polymer Journal, 1992. 28(5): p. 475-479. 100. Bednar, R.A., Reactivity and Ph-Dependence of Thiol Conjugation to N-Ethylmaleimide - Detection of a Conformational Change in Chalcone Isomerase. Biochemistry, 1990. 29(15): p. 3684-3690. 101. Lam, S., et al., Relationship between Types of Asthmatic Reaction, Nonspecific Bronchial Reactivity, and Specific Ige Antibodies in Patients with Red Cedar Asthma. Journal of Allergy and Clinical Immunology, 1983. 72(2): p. 134-139. 102. Brewer, C.F. and J.P. Riehm, Evidence for Possible Nonspecific Reactions between N-Ethylmaleimide and Proteins. Analytical Biochemistry, 1967. 18(2): p. 248-&. 103. Huang, Z., et al., Active inclusion bodies of acid phosphatase PhoC: aggregation induced by GFP fusion and activities modulated by linker flexibility. Microb Cell Fact, 2013. 12: p. 25. 104. Robinson, C.R. and R.T. Sauer, Optimizing the stability of single-chain proteins by linker length and composition mutagenesis. Proc Natl Acad Sci U S A, 1998. 95(11): p. 5929-34. 105. Pakhomov, A.A. and V.I. Martynov, GFP family: structural insights into spectral tuning. Chem Biol, 2008. 15(8): p. 755-64. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/59807 | - |
dc.description.abstract | 肝素結合凝血附著素 HBHA (heparin-binding haemagglutinin adhesion, HBHA) 為一源自於分枝桿菌表面的抗原蛋白,在本實驗室過去的研究中,我們發現由 HBHA 蛋白 C 端序列修改成之 HBHAc 是具有胞內遞輸能力的最小片段,接著,成功地將其應用於攜帶精胺酸去亞胺酶 (arginine deiminase, ADI) 、綠色螢光蛋白 (enhanced green fluorescent protein, EGFP) 以及細胞色素c (cytochrome c, cyt c) 至癌症細胞株內。此外,我們更發現 HBHAc-ADI 於人類乳癌細胞(MDA-MB-231)中表現出對酸鹼值敏感之遞送效果。因此,為了更進一步瞭解這個蛋白質載體對酸鹼值敏感的機轉以及找到 HBHAc 與其攜帶蛋白之間的最佳胜肽鍵結,本研究選擇綠色螢光蛋白作為模式蛋白,將 HBHAc 與綠色螢光蛋白利用融合蛋白或化學合成的方式連結,以綠色螢光蛋白的螢光活性評估 HBHAc 的遞送能力。而延續了本實驗室過去對於 HBHAc-EGFP 的研究,我們一樣選擇使用肝癌細胞(HepG2)作為體外試驗的給藥目標。
第一部份,我們利用大腸桿菌BL21 (DE3)菌株過度表現帶有 histidine-tag 之 EGFP 及 HBHAc-EGFP ,再使用 cOmplete His-Tag Purification Resin 作為親和性材料將蛋白純化。首先,我們將純化出的蛋白於不同酸鹼值的培養基環境下於 HepG2 細胞進行細胞攝取實驗,並使用流式細胞儀分析其進入細胞的效率。我們發現 HBHAc-EGFP 在不同酸鹼值下的細胞攝取量不同,當環境較為酸性時,其遞送進入細胞的效果會顯著增加,而EGFP在各種酸鹼值下被攝取入細胞的量都極少。MTT試驗結果則顯示此具有酸鹼選擇性之細胞遞送效果與不同酸鹼值之培養基之毒性沒有關聯性。 在證實 HBHAc-EGFP 的細胞遞送有酸鹼選擇性後,我們想進一步探討其進入細胞的機轉是否會受到於酸鹼值不同的影響,因此使用改變溫度或給予胞吞作用(endocytosis)化學抑制劑的方式來進行細胞攝取機轉方面的研究。我們發現在酸鹼值為 6.5 以及 7.5 下 HBHAc-EGFP 皆必須先與細胞膜表面的硫酸化醣蛋白結合後,再藉由胞吞作用進入細胞。然而,化學抑制劑的結果顯示,在酸鹼值為 6.5 時, HBHAc-EGFP 會透過由 dynamin 調節之胞吞作用被細胞攝取,而在酸鹼值為 7.5 ,其胞吞作用則受細胞膜表面之 lipid raft 影響。過去有研究指出物質之表面化學特性會影響其被攝取入細胞的機轉,因此我們推測其於不同酸鹼值下胞吞作用機轉的差異有可能就是因表面電荷的不同而造成。然而,雖然胞吞作用化學抑制劑的使用相當普遍,但其選擇性並不佳,因此,未來可能尚需要利用一些專一性較高抑制方式對於目前的結果做再次確認。 在第二部分的研究中,我們想要探討不同胜肽連接子對於 HBHAc 遞送效果的影響,使用了化學合成的方式將 HBHAc 或含有另外兩種不同胜肽連接子的 HBHAc 接在 EGFP 上。在酸鹼值為6.5時的結果顯示,與其他組別比起來,接上含有 flexible peptide linker 的 HBHAc 之 EGFP 被細胞攝取的量顯著的較低,因此flexible linker可能不適合用來連結 HBHAc 與 EGFP 。然而我們只有使用一種胜肽連接子的長度作測試,因此依照目前的研究結果,尚無法判斷rigid linker是否會對於細胞攝取的效率造成影響,故未來可能還要再嘗試不同長度的rigid linker以確認其效果。 | zh_TW |
dc.description.abstract | HBHAc is the minimal segment of heparin-binding haemagglutinin adhesion (HBHA), the surface antigenic protein of Mycobacterium tuberculosis, with the ability of intracellular delivery. According to previous studies from our lab, HBHAc has been successfully utilized to deliver arginine deiminase (ADI), enhanced green fluorescent protein (EGFP), and cytochrome c (cyt c) into cancer cell lines. In addition, HBHAc-ADI has been demonstrated with a pH selective intracellular delivery to MDA-MB-231. Thus, to further investigate the mechanism of this pH selective carrier, and to optimize the peptide linkage between HBHAc and its functional protein cargo, EGFP was employed as the model protein and fused with HBHAc through either recombination or chemical conjugation. Based on the former study of HBHAc-EGFP from our lab, we selected the human hepatocellular carcinoma cell line, HepG2, as our in vitro model.
For the first part of the study, recombinant histidine tagged EGFP and HBHAc-EGFP overexpressed in E. coli BL21 (DE3) were purified with cOmplete His-Tag Purification Resin. Uptake efficiencies of HBHAc-EGFP under different pH conditions were analyzed by flow cytometry. Results showed that when treated to HepG2 cells, HBHAc-EGFP showed a pH dependent cellular uptake, in which we observed that the internalization was higher under lower pH condition. The higher uptake efficiency of HBHAc-EGFP at pH 6.5 was not related to cytotoxicity, which was confirmed by MTT assay. Meanwhile, EGFP possessed very low permeability under all pH conditions. The mechanism of HBHAc-EGFP intracellular delivery under different pH conditions was investigated by the cellular uptake experiments under various conditions that each blocked a different component of an endocytosis pathway. Under both pH conditions, HBHAc-EGFP required binding to cell surface sulfated proteoglycans before internalized by endocytosis. However, the endocytic pathway of HBHAc-EGFP is different under pH 6.5 and 7.5. Results suggested that the internalization of HBHAc-EGFP in HepG2 cells was mediated by dynamin under pH 6.5, whereas it was related to lipid rafts under pH 7.5. It is possible that the different charges of HBHAc-EGFP under pH 6.5 and 7.5 resulted in the shift of its internalization mechanism. However, due to the lack of specificity of endocytosis inhibitors utilized, further confirmation with fluorescent tracers for specific endocytic pathways is required. For the second part of the study, HBHAc peptide with or without a peptide linker was chemically conjugated to EGFP to optimize the linkage type between HBHAc and EGFP. Reduced cellular uptake of EGFP conjugated with (GGGGS)2-HBHAc was observed under pH 6.5. This may be that the increased flexibility of fusion protein introduced by a flexible linker led to decreased intracellular delivery activity. Therefore, flexible linkers, such as (GGGGS)2, might not be suitable peptide linkers for HBHAc-EGFP. We are not yet able to confirm whether the addition of rigid linkers would affect the intracellular delivery efficiency of HBHAc-EGFP, due to only one linker length was utilized in this study. Thus, further confirmation with increased peptide linker lengths is needed. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T09:38:59Z (GMT). No. of bitstreams: 1 ntu-105-R03423016-1.pdf: 2517567 bytes, checksum: 7e04b818a2c7d0d941b0328ba17e0c22 (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 摘要 III
Abstract V List of Schemes and Figures VIII List of Tables X List of Abbreviations XI Chapter I: Introduction 1 1-1 General overview 1 1-2 Cell penetrating peptides (CPPs) 2 1-2-1 Heparin-binding haemagglutinin adhesin, HBHA 3 1-2-2 HBHAc 4 1-2-3 Mechanism of cellular uptake 5 1-3 Targeted drug delivery 7 1-3-1 pH stimulated targeting 8 1-4 Green fluorescent protein (GFP) 9 1-4-1 Discovery and application of green fluorescent proteins 9 1-4-2 Structure and chromophore of green fluorescent proteins 10 1-4-3 Application of EGFP in CPP researches 11 1-5 Fusion protein linkers 13 1-5-1 Classification and application of empirical protein linkers 14 Chapter II: Objectives and Aims 16 Chapter III: Materials and Methods 18 3-1 Materials 18 3-1-1 Cell culture 18 3-1-2 Recombinant protein expression and purification 19 3-1-4 Membrane competition assay 20 3-1-4 Endocytosis inhibition study 21 3-1-5 Preparation of EGFP conjugates 21 3-2 Cell culture 22 3-3 Expression and purification of recombinant proteins 22 3-3-1 Expression of recombinant proteins 22 3-3-2 Purification of recombinant proteins 23 3-3-3 Purity of the recombinant proteins 24 3-4 Zeta potential of recombinant proteins under different pH conditions 24 3-5 Fluorescence of HBHAc-EGFP under different pH conditions 24 3-6 Flow Cytometry analysis of the kinetics of pH-dependent cellular uptake 25 3-7 Cell viability assay 26 3-8 Analysis of pH-dependent cellular uptake mechanism 26 3-8-1 Temperature dependent study 26 3-8-2 Membrane competition assay 27 3-8-3 Endocytosis inhibition assay 28 3-9 EGFP conjugates 28 3-9-1 Preparation of EGFP conjugates 28 3-9-2 Cellular uptake of EGFP conjugates 30 3-10 Statistics analysis 30 Chapter IV: Results 32 4-1 Recombinant EGFP and HBHAc-EGFP expression and purification 32 4-2 Zeta potential of recombinant proteins under different pH conditions 32 4-3 Fluorescence of HBHAc-EGFP under different pH conditions 33 4-4 Uptake analysis of pH sensitive HBHAc-EGFP intracellular delivery 33 4-5 Cytotoxicity of recombinant proteins under different pH conditions 35 4-6 Mechanism of cellular uptake of HBHAc-EGFP under different pH conditions 35 4-6-1 Membrane competition study 35 4-6-2 Energy dependent assay 37 4-7 Modifications of the chemical conjugation of EGFP and HBHAc 40 4-8 Characteristics of EGFP conjugates 42 4-9 Cellular uptake of EGFP conjugates 42 Chapter V: Discussion 44 5-1 pH dependent cellular uptake of HBHAc-EGFP 44 5-2 Mechanisms of intracellular delivery of HBHAc-EGFP under different pH conditions 45 5-2-1 HBHAc-EGFP binds to heparan sulfate proteoglycans before internalization 45 5-2-2 Temperature and HBHAc-EGFP internalization 47 5-2-3 HBHAc-EGFP endocytic pathway under different pH conditions 48 5-3 Chemical conjugation of EGFP and HBHAc derived peptides 51 5-4 The effect of peptide linker in HBHAc protein delivery 53 Chapter VI: Conclusion and future prospective 55 References 81 | |
dc.language.iso | en | |
dc.title | 含穿胞胜肽HBHAc之重組綠色螢光蛋白於不同酸鹼值下
之胞內運輸暨不同胜肽連接子對胞內運輸影響之研究 | zh_TW |
dc.title | Study on the intracellular delivery of HBHAc-EGFP
under different pH conditions and the effect of peptide linkers | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 孔繁璐,許麗卿,梁碧惠 | |
dc.subject.keyword | 肝素結合凝血附著素,細胞穿膜胜?,胞內遞輸,綠色螢光蛋白,酸鹼值選擇性,胞吞作用,胜?連接子, | zh_TW |
dc.subject.keyword | heparin-binding haemagglutinin adhesion,cell-penetrating peptide,intracellular protein delivery,green fluorescence protein,pH sensitive,endocytosis,peptide linker, | en |
dc.relation.page | 89 | |
dc.identifier.doi | 10.6342/NTU201700437 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-02-09 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 藥學研究所 | zh_TW |
顯示於系所單位: | 藥學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-1.pdf 目前未授權公開取用 | 2.46 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。